A Mulicenter, Multi-Arm, Randomized , Multi-Dose, Placeb

Project: Research project

Project Details

Description

A Mulicenter, Multi-Arm, Randomized , Multi-Dose, Placebo-Controlled, Double-Blind, Phase 3 Study of Intravesical Apaziqone as a Surgical Adjuvant in the Immediate Postoperative Period in Patients Undergoing Transurethral Resection for Non-Muscle Invasiv
StatusFinished
Effective start/end date12/16/1612/15/17

Funding

  • Spectrum Pharmaceuticals, Inc.

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.